Over $2.5 million to Rémi Rabasa-Lhoret for research on the
artificial pancreas. Dr Rémi Rabasa-Lhoret research team at IRCM is receiving a grant of
more than $2.5M USD from the U.S. NIH for a clinical study on external artificial pancreas. The goal of
the project is to compare glucose control achieved using the single-hormone (insulin only) artificial
pancreas, the dual-hormone (insulin and glucagon) artificial pancreas, and the conventional insulin pump
to deliver insulin.
Dr Rabasa-Lhoret team is leading the field of artificial pancreas development
in Canada, a technology which has the potential to greatly reduce complication risks associated
to a poor glucose control in people with type 1 diabetes. Click here for the IRCM news release.
Dr Vincent Poitout was elected Fellow
of the Canadian Academy of Health Sciences.
AmorChem venture capital fund invests
at MDRC. Two projects of the MDRC researchers Marc Prentki and Nabil Seidah
have recently been funded by the venture capital fund AmorChem: more than 1 million and
1.5 million $, respectively. The shareholders of this fund are the Quebec government,
Fonds de solidarité FTQ and Merck. The mission of AmorChem is to increase the commercial
value of academic research discoveries in Quebec. Click here for an article in
La Presse about this news (in French).
MDRC success for a CFI competition - Creation
of the BIOcMET consortium. The Canada Foundation for Innovation (CFI) announced last
January 15 the attribution of a 6.5 million $ grant to fund the project entitled "The Montreal
Cardiometabolic biomarker and drug discovery consortium (BIOcMET)". This project is led by
Dr Marc Prentki, MDRC director. Among the 10 investigators involved in the project, 8 are MDRC
members: Drs Prentki, Poitout, Hamet, Turgeon, Gaudreau (UdM/CRCHUM), Rabasa-Lhoret, Seidah
(UdM/IRCM) and Sladek (McGill). The two other researchers are Drs Blanchette (McGill) and
Marc Prentki received the 2011 Albert Renold
Prize from the European Association for the Study of Diabetes (EASD) for
"outstanding achievements in research on the islets of Langerhans".
As part of the prize, Dr Prentki was invited to give the Albert
Renold Lecture at the 2011 EASD annual meeting. The title of his talk was:
"Tricycling along the β-cell and its coupling mechanisms for fuel-induced
2011 is an exceptional year of Canadian
Diabetes Association (CDA) funding for MDRC members: 8 of the 24 projects funded
across Canada this year were granted to MDRC members!
Pedro Geraldes receives the prestigious
"Scholar Award" of the CDA attributed to newly independent investigators
establishing diabetes-related research in a Canadian university.
Marc Prentki and Vincent Poitout's works
have been highlighted in Le donataire. A full page of the June
edition of Le donataire, the monthly newsletter of the CHUM foundation, has been dedicated
to describing the achievements of the laboratories of Drs Marc Prentki and Vincent Poitout.
Click here for a pdf version of
Jean-Pierre Hallé and Lawrence Rosenberg
have edited a book on bioartificial therapies and tissue transplantations.
Eighty-one scientists from 32 institutions in 12 different countries have contributed to
the book entitled “The Bioartificial Pancreas and other Biohybrid Therapies”, edited by
Drs Hallé and Rosenberg.